FDA Drug Application (021526) for RANEXA by GILEAD

Back to FDA Applications sponsored by GILEAD

Application Number021526
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage1GM
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRANEXA
Active IngredientRANOLAZINE

Active IngredientCount
List of drugs with Active Ingredient RANOLAZINE2


Back to FDA Applications sponsored by GILEAD